180 Bloor St. West
Queen’s University at Kingston, B.A., (Hons.)
University of Toronto, J.D.
Harvard University, M.P.H.
BAR & COURT ADMISSIONS
Member, Law Society of Upper Canada
Member, Ontario Bar
Mr./ Professor Neil Seeman, a Canadian-trained attorney and Internet researcher, is the founder, Chairman, President and Chief Executive Officer of RIWI Corp. (Canadian Securities Exchange: RIW). RIWI is a global survey, global ad testing and predictive analytics firm, which first gained attention from the international risk community in 2011 for tracking and predicting online the fall of Hosni Mubarak, the former Egyptian military and political leader. As CEO, Neil leads overall strategy for the company globally, with a focus on healthcare and international security solutions. He is responsible for overall company performance.
RIWI data help global organizations monitor and adapt to changing citizen needs and behavior patterns, and help clients adjust to new risks and sentiment shifts occurring in all countries. Profiled in Nature, The Lancet and other scholarly journals, RIWI works with government agencies and global organizations such as the US Department of State, Israel’s Ministry of Foreign Affairs, The World Bank, the United Nations, the Bill and Melinda Gates Foundation, the Inter-American Development Bank (IDB), Credit Lyonnais Securities Asia (CLSA), Procter & Gamble, Ericsson, Deloitte and Omidyar Network. RIWI’s long-term clients in the financial services sector include firms engaging RIWI to predict the outcomes of referenda and elections with laser-like precision, to detect demand- and counter-demand signals for goods and services across Asia, Africa, Europe and the Middle East, and to monitor geopolitical risk and systemic risk in all information environments in the world.
Prior to joining RIWI Corp., he was the founder and Executive Director of the Innovation Cell at Massey College, in the University of Toronto, where Neil is a Senior Fellow and teaches on knowledge transfer and the Web. For the University, he is on Faculty at the Institute of Health Policy, Management and Evaluation in the Dalla Lana School of Public Health.
In the field of global pandemic surveillance, Neil was the first to coin the term "online counter-marketing" in a 2010 paper in the journal Healthcare Quarterly, and to explain its significance and detail novel online solutions to fighting disinformation online in public health. Different firms engaged by RIWI apply these principles today in many fields, including in the area of countering violent extremism.
Neil is the inventor of the patent for RDIT, acquired by RIWI Corp. in 2009, and first used by Neil for government-commissioned pandemic surveillance research in 2009-2010. Neil holds a bachelor’s degree from Queen’s University, a Juris Doctorate degree from the University of Toronto and a Master’s of Public Health Degree from Harvard University.
Mr. Seeman is the author of hundreds of articles in major media around the world, more than 25 peer-reviewed journal papers, several books and monographs, and is well-known for popularizing the importance of post-partisanship in data and decision-making for public policy.
Mr. Seeman began his career at a full-service Canadian law firm, later becoming a founding editorial board member of The National Post, and In-House Counsel on free speech matters to the National Citizen’s Coalition serving under the leadership of Stephen Harper, the former Prime Minister of Canada. He was founder of the Canadian Statistical Assessment Service, funded by the Donner Canadian Foundation, and later merged with the Centre for Risk and Regulation at The Fraser Institute, the economic think-tank He has held research positions at the University of Toronto Faculty of Medicine and at IBM, where he specialized in commercial applications of social media data and other online data streams. Prior to the University of Toronto, he taught on healthcare and informatics issues at Ryerson University. He has been an an advisor and early-stage investor to many Web companies, notably digital media firm J2 Global Inc. (NSDQ: JCOM). He has been listed in the Canadian Who’s Who (Univ. of Toronto) since 2002.
His academic work has appeared in major journals such as Nature, Synapse, and the Canadian Medical Association Journal. RIWI is winner of the IIeX Innovation Exchange (2013), a 5-year consecutive ‘Top 50 Most Innovative’ data firm (2013-2017), and Neil is winner of the NGMR ‘Disruptive Innovator of the Year’ award (2014). His research is often cited in global media, such as The Economist, CNBC and The Wall Street Journal - and he is a frequent public speaker around the world on data innovation and digital healthcare.